FDA’s Data Format Standards Approaching Cost-Benefit Analysis Stage
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency sets a meeting for November and wants comments in advance on potential candidates for a format that will reduce the need for data integration steps between its various systems.